Can HIV Be Cured and Should We Try?
作者信息
Cummins Nathan W, Badley Andrew D
机构信息
Division of Infectious Diseases, Mayo Clinic, Rochester, MN.
Division of Infectious Diseases, Mayo Clinic, Rochester, MN.
出版信息
Mayo Clin Proc. 2015 Jun;90(6):705-9. doi: 10.1016/j.mayocp.2015.03.008. Epub 2015 May 2.
Abstract
摘要
相似文献
1
Can HIV Be Cured and Should We Try?艾滋病毒能被治愈吗？我们应该尝试吗？
Mayo Clin Proc. 2015 Jun;90(6):705-9. doi: 10.1016/j.mayocp.2015.03.008. Epub 2015 May 2.
2
Scientists investigate routing latent HIV from its reservoirs to achieve a cure.科学家们研究如何将潜伏在储存库中的艾滋病毒清除以实现治愈。
JAMA. 2012 Jul 25;308(4):325-7. doi: 10.1001/jama.2012.8466.
3
HIV: Cure by killing.艾滋病病毒：通过杀灭实现治愈。
Nature. 2015 Dec 10;528(7581):198-9. doi: 10.1038/nature16321. Epub 2015 Dec 2.
4
Shot in the HAART: vaccine therapy for HIV.抗逆转录病毒疗法中的新尝试：HIV疫苗疗法
Lancet Infect Dis. 2014 Apr;14(4):259-60. doi: 10.1016/S1473-3099(13)70331-1. Epub 2014 Feb 11.
5
What Will It Take to Cure HIV?治愈艾滋病毒需要什么？
Top Antivir Med. 2015 May-Jun;23(2):80-4.
6
Compartmentalization, Viral Evolution, and Viral Latency of HIV in the CNS.HIV在中枢神经系统中的区室化、病毒进化及病毒潜伏
Curr HIV/AIDS Rep. 2015 Jun;12(2):262-71. doi: 10.1007/s11904-015-0265-9.
7
Exploring how to get at--and eradicate--hidden HIV.探索如何发现并消除隐藏的艾滋病毒。
Science. 1998 Mar 20;279(5358):1854-5. doi: 10.1126/science.279.5358.1854.
8
30 years after HIV identification: where to from here?发现艾滋病毒30年后：未来何去何从？
Expert Rev Anti Infect Ther. 2011 Nov;9(11):947-9. doi: 10.1586/eri.11.127.
9
Ending AIDS--is an HIV vaccine necessary?终结艾滋病——HIV疫苗是必要的吗？
N Engl J Med. 2014 Feb 6;370(6):495-8. doi: 10.1056/NEJMp1313771.
10
[Advances in management of HIV infections].[艾滋病毒感染的管理进展]
Internist (Berl). 2012 Oct;53(10):1149-50. doi: 10.1007/s00108-011-2975-4.
引用本文的文献
1
The Future of Gene Expression Studies in HIV Research.HIV研究中基因表达研究的未来。
Curr HIV Res. 2025;23(1):28-34. doi: 10.2174/011570162X361179250204061607.
2
The Use of Broadly Neutralizing Antibodies (bNAbs) in HIV-1 Treatment and Prevention.广泛中和抗体（bNAbs）在 HIV-1 治疗和预防中的应用。
Viruses. 2024 Jun 4;16(6):911. doi: 10.3390/v16060911.
3
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection - Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug Resistance.社论：等待预防和治愈 HIV 感染的四十年——疫苗开发和克服抗逆转录病毒药物耐药性的持续挑战和希望。
Med Sci Monit. 2024 Apr 1;30:e944600. doi: 10.12659/MSM.944600.
4
Hypertension among persons living with HIV/AIDS and its association with HIV-related health factors.HIV/AIDS 患者中的高血压及其与 HIV 相关健康因素的关系。
AIDS Res Ther. 2024 Jan 11;21(1):5. doi: 10.1186/s12981-023-00576-2.
5
Natural killer cells induce HIV-1 latency reversal after treatment with pan-caspase inhibitors.自然杀伤细胞在使用泛半胱天冬酶抑制剂治疗后诱导 HIV-1 潜伏期逆转。
Front Immunol. 2022 Dec 6;13:1067767. doi: 10.3389/fimmu.2022.1067767. eCollection 2022.
6
Utility of Proteomics in Emerging and Re-Emerging Infectious Diseases Caused by RNA Viruses.蛋白质组学在由 RNA 病毒引起的新发和再发传染病中的应用。
J Proteome Res. 2020 Nov 6;19(11):4259-4274. doi: 10.1021/acs.jproteome.0c00380. Epub 2020 Oct 23.
本文引用的文献
1
Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection.HIV精英控制者和医学控制的HIV感染者的住院率及原因
J Infect Dis. 2015 Jun 1;211(11):1692-702. doi: 10.1093/infdis/jiu809. Epub 2014 Dec 15.
2
How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs?急性感染中抗逆转录病毒疗法开始的时机如何影响艾滋病毒储存库？
Curr Opin HIV AIDS. 2015 Jan;10(1):18-28. doi: 10.1097/COH.0000000000000122.
3
Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity.广谱中和抗 HIV-1 抗体需要 Fc 效应功能才能在体内发挥作用。
Cell. 2014 Sep 11;158(6):1243-1253. doi: 10.1016/j.cell.2014.08.023.
4
Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice.广泛中和抗体和病毒诱导剂可减少人源化小鼠中HIV-1潜伏库的病毒反弹。
Cell. 2014 Aug 28;158(5):989-999. doi: 10.1016/j.cell.2014.07.043. Epub 2014 Aug 14.
5
Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1.预测根除HIV-1潜伏储存库的治疗结果。
Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):13475-80. doi: 10.1073/pnas.1406663111. Epub 2014 Aug 5.
6
Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases.异基因干细胞移植后无抗逆转录病毒治疗的HIV-1缓解及病毒反弹：2例报告
Ann Intern Med. 2014 Sep 2;161(5):319-27. doi: 10.7326/M14-1027.
7
Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells.在原发性HIV-1感染时开始的长期抗逆转录病毒治疗会影响HIV-1感染的CD4 T细胞储存库的大小、组成和衰减动力学。
J Virol. 2014 Sep 1;88(17):10056-65. doi: 10.1128/JVI.01046-14. Epub 2014 Jun 25.
8
New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo.新的离体方法可区分体内有效和无效的逆转 HIV-1 潜伏期的单一药物。
Nat Med. 2014 Apr;20(4):425-9. doi: 10.1038/nm.3489. Epub 2014 Mar 23.
9
Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.对感染 HIV 人群的自体 CD4 T 细胞中的 CCR5 进行基因编辑。
N Engl J Med. 2014 Mar 6;370(10):901-10. doi: 10.1056/NEJMoa1300662.
10
An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients.深入比较多种细胞模型系统和抗逆转录病毒治疗的患者静息 CD4+T 细胞中的潜伏 HIV-1 再激活。
PLoS Pathog. 2013;9(12):e1003834. doi: 10.1371/journal.ppat.1003834. Epub 2013 Dec 26.
Zotero 插件